Previous Article | Next Article ![]()
Microbiol Mol Biol Rev, June 1998, p. 334-361, Vol. 62, No. 2
Instituto de Investigaciones
Biomédicas, Unidad de Bioquímica y Genética de
Levaduras, CSIC, 28029 Madrid, Spain
1092-2172/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Yeast Carbon Catabolite Repression
SUMMARY
INTRODUCTION
LEVELS OF CONTROL
ELEMENTS OF THE SYSTEM
Activators
The Hap2/3/4/5 complex.
Gal4.
Mal63.
Adr1.
Other activators.
Repressors
The Mig1 complex.
Other repressors.
Intermediary Elements
The Snf1 complex.
The Glc7 complex.
Elements Involved in Glucose Signaling
Elements Which Play an Indirect Role
The Snf/Swi complex and the SPT proteins.
The mediator.
The Ada/Gcn5 complex.
Other elements.
REGULATION OF SPECIFIC GENES
The GAL Genes
SUC2
FBP1
ADH2
CYC1
Other Genes
CONCLUSIONS AND PERSPECTIVES
ACKNOWLEDGMENTS
REFERENCES
SUMMARY
|
|
|---|
Glucose and related sugars repress the transcription of genes encoding enzymes required for the utilization of alternative carbon sources; some of these genes are also repressed by other sugars such as galactose, and the process is known as catabolite repression. The different sugars produce signals which modify the conformation of certain proteins that, in turn, directly or through a regulatory cascade affect the expression of the genes subject to catabolite repression. These genes are not all controlled by a single set of regulatory proteins, but there are different circuits of repression for different groups of genes. However, the protein kinase Snf1/Cat1 is shared by the various circuits and is therefore a central element in the regulatory process. Snf1 is not operative in the presence of glucose, and preliminary evidence suggests that Snf1 is in a dephosphorylated state under these conditions. However, the enzymes that phosphorylate and dephosphorylate Snf1 have not been identified, and it is not known how the presence of glucose may affect their activity. What has been established is that Snf1 remains active in mutants lacking either the proteins Grr1/Cat80 or Hxk2 or the Glc7 complex, which functions as a protein phosphatase. One of the main roles of Snf1 is to relieve repression by the Mig1 complex, but it is also required for the operation of transcription factors such as Adr1 and possibly other factors that are still unidentified. Although our knowledge of catabolite repression is still very incomplete, it is possible in certain cases to propose a partial model of the way in which the different elements involved in catabolite repression may be integrated.
INTRODUCTION
|
|
|---|
Saccharomyces cerevisiae and many other yeasts may thrive on a variety of carbon sources, but glucose and fructose are the preferred ones. When one of these sugars is present, the enzymes required for the utilization of alternative carbon sources are synthesized at low rates or not at all. This phenomenon is known as carbon catabolite repression, or simply catabolite repression, and since no "catabolite" derived from glucose and involved in the repression has been yet identified, the term "glucose repression" has also been proposed. In this review, I still use the term "catabolite repression" as well as glucose repression, to stress that other sugars, such as galactose or maltose, are able to affect the synthesis of enzymes repressed by glucose (Table 1).
|
A comprehensive picture of the mechanism(s) of catabolite repression is not yet available, in spite of the accumulation of information on the subject (for earlier reviews, see references 95, 96a, 96b, 124, 163, 289, and 346). Although the solution of the puzzle has progressed, important pieces are still missing and it has been found that other pieces, originally thought to belong, do not really pertain to the basic frame. The last few years have seen important advances, which are reviewed and discussed in this article. I also propose some models for catabolite repression of different genes and discuss some perspectives for future research. Although the review deals mainly with S. cerevisiae, reference to other yeast species is made, as far as information is available.
For easy reference, Table 2 provides an overview of the alternative names given to genes related to catabolite repression, since these genes have been repeatedly isolated by different groups and given different names.
|
LEVELS OF CONTROL
|
|
|---|
Glucose may affect enzyme levels by causing a decrease in the concentration of the corresponding mRNAs, a decrease in their translation rate, or an increase in the degradation rate of the protein. In turn, mRNA levels would depend both on the rate of transcription of the corresponding gene and on the stability of the mRNA. The main effect of glucose takes place at the transcriptional level; accordingly, this review deals mainly with this mechanism of regulation. Nevertheless, alternative mechanisms which are operative in certain cases are briefly discussed in this section.
Control of the mRNA translation rate is not common in yeast; however, in the case of the transcriptional activator Adr1, glucose appears to act at this step. While the concentration of Adr1 is at least 10-fold higher in ethanol-grown yeast than in glucose-grown yeast, there is only a 2-fold difference in the levels of the corresponding mRNAs (354). Since the half-life of Adr1 itself is not longer in ethanol-grown cells than in glucose-grown cells, it has been concluded that the observed decrease in the level of Adr1 is due mainly to a reduction in the rate of Adr1 synthesis brought about by glucose. The molecular mechanism by which glucose acts remains unclear, but it has been shown that the translational control does not depend on the long untranslated 5' leader sequence of ADR1 mRNA (354). Removal of the gene sequence corresponding to the 681 C-terminal residues of Adr1 (more than half the length of the protein) did not disrupt the translational control, but the ADR1 coding sequence between amino acids 262 and 642 is required for the control of ADR1 translation by glucose.
While translational control by glucose is rare, glucose triggers inactivation and/or proteolysis of a number of proteins. By analogy to catabolite repression, this phenomenon has been called catabolite inactivation (151); it affects a variety of proteins, from gluconeogenic enzymes to transport molecules, but it is not yet known whether the same mechanism underlies the inactivation in the different cases (125a). Inactivation of fructose-1,6-bisphosphatase (FbPase) by glucose (121) has been most extensively studied, and it has been shown that glucose causes a very rapid phosphorylation of FbPase and a proteolytic degradation of the enzyme (119, 224, 225, 236). Two alternative mechanisms for the proteolysis have been described: (i) transfer of FbPase to the vacuole and degradation by vacuolar proteases (56), and (ii) ubiquitination of FbPase (310) followed by degradation by the proteasome (309). The relative contribution of each pathway could depend on the physiological state of the yeast (306). Proteolysis of FbPase triggered by glucose can occur even in the absence of phosphorylation (291), but it has not been established whether phosphorylation may be a requirement or a facilitator of at least one of the degradation systems. The mechanism by which glucose triggers the proteolysis is not known, but glucose appears to induce the synthesis of proteins required for the degradation process. Some of these proteins would be transported to the vacuole, via the secretory pathway, and facilitate the uptake of FbPase by the vacuole (56). Other proteins would be required for ubiquitination of FbPase and its degradation in the proteasome (310). Recently, a series of mutants have been isolated in which inactivation and degradation of FbPase are uncoupled and the inactive protein accumulates in the cytosol and in small vesicles in the cytoplasm (149). Although the proteins involved in the process have not been identified yet, there is some evidence that in wild-type cells, FbPase could be imported in cytoplasmic vesicles before being degraded in the vacuole (155).
The most general system of catabolite repression involves a parallel decrease in mRNA and protein levels. Glucose has been reported to destabilize the corresponding mRNAs in a few systems: the functional half-life of CYC1 mRNA was shown to decrease from 12 min in derepressed cells to about 2 min when glucose was present (400, 401); for MAL6S (MAL62) mRNA the decrease was from 25 to 6 min (107); glucose also had a very strong effect on the mRNAs encoding subunits of succinate dehydrogenase, decreasing the half-life from more than 60 min to less than 10 min (198); for PCK1 mRNA, glucose accelerated the degradation rate only twofold (230). In no case, however, was information available about a possible mechanism for this effect of glucose.
More recently, it has been shown that the 5' untranslated end of the mRNA encoding the iron protein (Ip) subunit of succinate dehydrogenase is able to promote rapid degradation of a fusion mRNA upon glucose addition (48). The 5' exonuclease Xrn1 seems to play an important role in the mRNA degradation, and it has been suggested that the rate of degradation of mRNA could be set by a competition between initiation of translation and nuclease action (48). In this case, glucose could promote mRNA degradation by blocking mRNA translation. Phosphorylation of glucose or fructose was required to trigger Ip mRNA turnover, but any of the hexose kinases would be effective. Although further metabolism of the hexose phosphate formed does not seem to be required (both glucose and fructose increased turnover in a pgi mutant), addition of 2-deoxyglucose to a derepressed yeast culture did not decrease Ip mRNA stability (49). A possible interpretation for this could be that 2-deoxyglucose would decrease ATP levels and that the triggering of mRNA degradation would be energy dependent. Most factors required for glucose repression of genes such as SUC2 or the GAL genes (Hxk2, Grr1, Tup1, and Cyc8) did not markedly affect mRNA turnover in the presence of glucose, and the protein Ume5 (Srb10), which has been reported to destabilize SPO13 mRNA in a glucose-containing medium (331), was not needed for differential turnover of Ip mRNA (49). On the other hand, the regulatory protein Reg1 was required for increased degradation of Ip mRNA upon glucose addition (49).
The mechanism(s) regulating mRNA turnover in response to the carbon source remain to be worked out, but it is clearly established that for a subset of genes regulated by glucose, control is operating on mRNA stability instead of (or in addition to) on transcription rates. However, in the rest of this review, catabolite repression is considered in the narrow sense of the repression of transcription caused by glucose, since, as mentioned above, this is the major control mechanism.
ELEMENTS OF THE SYSTEM
|
|
|---|
Glucose and other repressing sugars can affect the rate of transcription by two basic mechanisms: they interfere with activators of transcription, or they facilitate the action of proteins with a negative effect on transcription. In bacteria, one or the other of these control mechanisms regulates catabolite repression in different species (297). Our present picture is that in yeast, the different sugars do not act directly on DNA-binding proteins but produce signals that are transmitted through a series of proteins to the promoters of the corresponding genes. To unravel the mechanisms of catabolite repression, it is therefore necessary to identify the signals produced by the sugar, the proteins which respond to them, and their substrates, down to the proteins binding to the promoter of the regulated genes.
To find the different elements that participate in the cascade of reactions between glucose and the final target, mutants affected in the process have been invaluable. Two kinds of mutants were sought, mutants for which glucose was no longer repressing and mutants in which derepression did not occur even when the glucose in the medium had been used up. To obtain these mutants, a variety of strategies were used (see reference 125 for a review), and the number of different genes isolated has increased in a bewildering manner. However, in the last few years it has become apparent that a number of these genes are not specifically related to the control by glucose but play a more general role in the control of transcription.
In the following sections, we consider in detail the different elements of the system: proteins which act as specific transcriptional repressors or activators, intermediary regulatory factors, and elements involved in glucose signalling. A number of proteins which somehow affect catabolite repression but are not directly involved in the response to glucose are also discussed.
Activators
The Hap2/3/4/5 complex. A large number of genes are regulated by a complex containing the proteins Hap2, Hap3, Hap4, and Hap5 (see reference 79 for a compilation of such genes). The complex, which activates transcription when yeast grows on a nonfermentable carbon source, binds DNA and makes contacts with a consensus ACCAA(T/C)NA sequence called the CCAAT box (255). In a search for yeasts unable to activate a CCAAT box-containing fusion gene, hap2, hap3, and hap4 mutants were isolated (114, 134, 136). Hap5 was identified by the two-hybrid assay with the core region of Hap2 as a bait (227). Hap2, Hap3, and Hap5 are absolutely required for CCAAT-binding activity, as shown in band shift experiments, and the three subunits are also sufficient for DNA binding, since a mixture of the three purified recombinant proteins allows binding to a CCAAT box in vitro (227). This is in contrast to initial reports that Hap4 was required for binding (114). It appears now that Hap4 is mainly responsible for the activation of transcription produced by the complex (257). The stoichiometry of the complex is not yet clear, but it has been reported to contain a single Hap2 molecule (384).
A 60-amino-acid core region of Hap2 is sufficient for functionality: within this region, there is a DNA binding domain and a subunit association domain (256, 257). This last domain is essential for interactions between Hap2 and other subunits of the complex and is able to form a helical structure (384). The DNA-binding domain of Hap2 is a 21-amino-acid region in which three critical histidines and three critical arginines have been identified (383). Hap3 contains also a 7-amino-acid region required for DNA binding, but its subunit association domain has not been clearly delineated (383). It has been proposed that Hap5 interacts with both Hap2 and Hap3 and brings the proteins together, allowing the interaction between the DNA-binding domains of Hap2 and Hap3 (227). The proteins Hap3 and Hap5, but not Hap2, contain the histone fold motif, a structural feature first identified in histones and now found in a large group of proteins, involved in protein-protein and/or protein-DNA interactions (8). It is not clear to what extent glucose affects Hap2 levels, since it was reported (272) that glucose decreased the levels of the HAP2 transcript fivefold whereas it was stated later that HAP4, "unlike HAP2 and HAP3," was induced fivefold when yeast cells were shifted from glucose to lactate (114). The effect of glucose on HAP4 is clearer, and the presence of a strong Mig1 binding site in the promoter of HAP4 suggested that catabolite repression of HAP4 would operate through Mig1 (79). However, it has been found that HAP4 is still repressed by glucose in a mig1 mutant (200). A possible interpretation for this observation is that an analog of Mig1, Mig2 (see the section on repressors, below), is sufficient to maintain HAP4 in a repressed state. Although it has been established that genes such as CYC1 or COX6, regulated by the Hap2/3/4/5 complex, require Snf1 for derepression (382), there have been no reports on a possible role of Snf1 on HAP4 expression. The interesting observation has been made that while the expression of CYC1-lacZ in a galactose medium decreases over 25-fold in a hap2 or a hap3 mutant, the decrease is less than 4-fold in a hap4 mutant (67). This could suggest that the Hap2/3/4/5 complex plays a double role: remodeling of the chromatin structure, which does not require Hap4, and direct activation of the RNA polymerase, in which Hap4 would be involved. In fact, a short region of the general transcription factor TFIIB, which contains an amphipathic helix unique to yeast TFIIB, is specifically required for activation of transcription by the Hap2/3/4/5 complex (315). Homologs of the HAP genes have been identified in other yeast species. In Schizosaccharomyces pombe, the php2 gene is able to complement an S. cerevisiae hap2 mutant, but in contrast to S. cerevisiae, the capacity of cellular extracts of S. pombe to bind to a CCAAT probe was similar for glucose- and glycerol-grown cells (256). Nevertheless, since disruption of php2 made S. pombe unable to grow in glycerol, the fission yeast gene also appears to be involved in mitochondrial function. The situation is different in Kluyveromyces lactis, where disruption of the functional homologs of HAP2 or HAP3 had no significant effect on the growth of the yeast on respiratory substrates (235, 248).Gal4. The protein Gal4 (184) activates the transcription of a family of genes, GAL1, GAL2, GAL7, GAL10, and MEL1, involved in the catabolism of galactose and melibiose (for a review, see references 161 and 228). These genes contain one to four copies of a regulatory element, UASGAL, with the palindromic consensus binding site CGGA(G/C)GACAGTC(C/G)TCCG (129), to which Gal4 can bind.
Gal4 has a DNA binding domain at the N terminus, which is a C6 zinc cluster (162), and two acidic activation regions, one near the DNA binding domain and the other at the C terminus (206). Gal4 is found as a monomer in the absence of DNA, but it binds to DNA as a dimer, with the C6 zinc clusters making contacts with a conserved CCG triplet at each end of the site (213). A short coiled-coil dimerization element of Gal4 is responsible for the symmetrical binding (35). Gal4 forms a complex with the regulatory protein Gal80 (129), and this formation requires the carboxy-terminal 30 amino acids from Gal4 (206). In the absence of galactose in the medium, the complex binds to UASGAL but is not able to activate transcription (129); when galactose is present, the regulatory protein Gal3, a protein with strong homology to galactokinase, binds Gal80, thereby relieving its inhibitory action on Gal4 (333, 388). Since Gal4 has been shown to occur in vivo in different phosphorylation states, it has been proposed that regulated phosphorylation modulates Gal4 activity (239). Although Gal4 can be phosphorylated at multiple sites, phosphorylation at Ser-699 plays a special role, since it is required for maximal activated transcription (296). There is evidence that phosphorylation of Gal4 takes place after Gal4 has stimulated the assembly of the general transcriptional machinery (228). When there is glucose in the medium, transcription of the GAL genes is repressed even if galactose is also present (1). Glucose could act on Gal4 at different levels: preventing its synthesis, blocking its capacity to bind to the UASGAL site, or interfering with its activating function. Expression of GAL4 is moderately repressed by glucose, and this repression involves the binding of the regulatory protein Mig1 to the GAL4 promoter (133, 241). In addition, glucose interferes with the release of the inhibition of Gal4 by Gal80 performed by galactose (164). This could be related to the observation that in the presence of Gal80, glucose prevents the phosphorylation of Gal4 (296). In a gal80 mutant with constitutive expression of Gal4, the activity of Gal4 appears to be unaffected by glucose (328) and the replacement of Ser-699 by alanine has no effect on the capacity of Gal4 to activate transcription (296). In K. lactis a transcriptional activator called Lac9, equivalent to Gal4, has been identified (302). Lac9 and Gal4 are operative in the heterologous yeast (286, 302), even though they have diverged considerably and homologies between them are restricted to areas of the protein implicated in nuclear localization, DNA binding, and transcriptional activation. The main regulatory features of the system have been conserved, with some interesting variations. In K. lactis, there is a KlGal80 protein that is very similar to the Gal80 protein and is able to block transcriptional activation by Lac9 in the absence of galactose (394). In contrast, there is no protein homologous to Gal3, and its function is taken by the galactokinase itself. A KlGal1-KlGal80 complex can be formed in the presence of galactose and ATP (395), and its formation is relevant for the expression of the GAL genes in K. lactis, as shown by the fact that a mutant protein KlGal1-m1 with galactokinase activity but unable to form a complex with KlGal80 has lost its regulatory function (395). Very large differences between strains, from no repression to 100-fold repression by glucose of the GAL genes from K. lactis, have been observed (24). These differences have been shown to depend on the LAC9 allele present in the strain. A 2-base difference in the LAC9 promoter region modifies the level of expression of the gene, and the small change (two- to threefold) in the concentration of the regulatory protein produces large effects in the expression of the GAL genes (178, 392). In contrast to the situation in S. cerevisiae, in K. lactis the absence of KlGal80 is sufficient to relieve the repression by glucose (394).Mal63. In different S. cerevisiae strains, the genes required for maltose utilization may be found at different loci called MAL1, MAL2, MAL3, MAL4, or MAL6. The most extensively studied gene complex is MAL6; in this complex, MAL61 (MAL6T) encodes maltose permease, MAL62 (MAL6S) encodes maltase, and MAL63 (MAL6R) encodes a protein which activates the expression of the genes MAL61 and MAL62 and probably that of the MAL63 gene itself (51, 240).
The protein Mal63 belongs to the same family of C6 zinc cluster proteins as Gal4 (50, 168). In contrast to Gal4, it is found as a dimer even in the absence of DNA (323) and it lacks acidic or glutamine-rich regions which appear associated with the capacity to activate transcription in other systems. The DNA recognition motif for Mal63 has not been clearly established; it was first suggested that the sequence GAAA(A/T)TTTCGC, found twice in a 68-bp region situated between the MAL61 and MAL62 genes and necessary for their maltose-induced expression, could be important (188). However, a footprint assay revealed three protected sites in the MAL61-MAL62 promoter, none of which corresponded to this sequence (323). Among these sites, one contains the sequence CGGN9CGG, a structure similar to that bound by the zinc cluster protein Hap1 (396) and another contains the sequence CGCN9CGC; the third one looks like a half-site sequence. In addition, a sequence in the promoter of MAL63 itself which binds Mal63 (240) has a similar motif, CGGN9CGC. In all these sequences, the intermediary N9 region is very AT rich. There is at present no information about the mechanism by which Mal63 is activated in the presence of maltose, although it has been speculated that maltose may bind to Mal63, yielding a conformation with functional activity (369). Constitutive alleles of MAL63, or the wild-type allele of MAL43 (an equivalent gene in the MAL4 locus), have multiple amino acid substitutions in the C-terminal region and may adopt the active conformation, even in the absence of maltose (369). Glucose represses the expression of the MAL genes, even when maltose is present in the medium (107, 154), and it appears to affect both MAL63 transcription and the formation of the active conformation of Mal63 (154, 369). The effect on MAL63 transcription is mediated largely by Mig1 as the disruption of MIG1 (154) or the removal of a Mig1 binding site in the MAL63 promoter (369) increases MAL63 expression in the presence of glucose. On the other hand, glucose may also cause inducer exclusion, perhaps by inactivating the maltose permease (27, 131), thereby preventing the conformational change of Mal63. Glucose repression of the MAL genes decreases strongly in strains carrying constitutive alleles of the regulatory proteins Mal63 or Mal43 (154, 369). In Candida albicans, an
-glucosidase encoded by
the CAMAL2 gene is induced by both maltose and
sucrose and repressed by glucose (127). The regulatory
gene CASUC1, which is also required for the
utilization of sucrose or maltose, encodes a C6 zinc
cluster protein with 28% identity to the Mal63 protein from
Saccharomyces and able to complement a mal63
mutation (167). An inspection of the promoter regions of
CASUC1 and CAMAL2 reveals a number of
sequences with some similarity to the consensus sequence able to bind
Mig1 in S. cerevisiae, but none of them seems likely to have a strong affinity for this protein (200). However, a
putative homolog of Mig1 has been only recently identified in C. albicans (393), and there is not yet any information on
its precise requirements for DNA binding. It therefore remains possible
that catabolite repression of the
-glucosidase from
Candida, like that of its Saccharomyces
counterpart, is partly mediated by Mig1.
Adr1. Adr1 is a zinc finger protein belonging to the C2H2 family (138), identified as a positive effector of the expression of ADH2, a gene which is repressed by glucose and which encodes alcohol dehydrogenase II (57). Adr1 has been localized in the nucleus, and its zinc fingers are essential for DNA binding (14). Adr1 binds a 22-bp palindromic sequence in the promoter of ADH2 (94) and may also bind sequences in the promoters of genes encoding peroxisomal proteins or proteins involved in glycerol utilization (266, 320). A consensus sequence for Adr1 binding, C(T/C)CC(A/G)N6-38(T/C)GG(A/G)G, has been proposed (53).
Several regions in Adr1, named TADI to TADIII, may act as transcription activation domains (60); a fourth region (TADIV) would be required for the activation of peroxisomal genes (322). To activate transcription efficiently, Adr1 requires a coactivator complex which includes among its components Ada2 and the histone acetyltransferase Gcn5 (55). There is evidence that Ada2 interacts specifically with TADII while Gcn5 may interact with any of the four TADs. In addition, TADI and TADIV bind to the C-terminal half of the RNA polymerase II subunit TFIIB (55). It would appear, therefore, that Adr1 interacts with several components of the coactivator complex, thus facilitating the acetylation of histones and a nucleosomal rearrangement which allows transcription to proceed (362). The interaction with TFIIB could also recruit the transcriptional machinery to the promoter, contributing further to the activation of the gene regulated by Adr1. Adr1 activity is sensitive to catabolite repression, with glucose acting at different levels; the relative importance of the different effects of glucose may vary depending on the genetic background. Glucose decreases the rate of transcription of ADR1 10- to 20-fold in some strains and has no significant effect in others (15). In a yeast strain where ADR1 was not repressed by glucose, a mutation in any of the genes SAF1, SAF2, or SAF3 made ADR1 sensitive to glucose (61). Although this may be related to the differences observed between strains, there have been no further reports on the role of the SAF genes. Since transcription of ADR1 is inhibited when the activity of the cyclic AMP (cAMP)-dependent protein kinase is unregulated (82), a possible way for glucose to affect ADR1 expression would be through an increase in the cAMP level. An effect of glucose on the stability of the ADR1 mRNA has also been observed; in the presence of glucose, the half-life of the mRNA decreases from about 2 h to 45 min (61). The main effect of glucose, however, appears to be on ADR1 mRNA translation, as discussed in the section on levels of control (above). It had also been reported that glucose could act at a posttranslational level. Since Adr1 is a substrate for cAMP-dependent protein kinases in vitro and since increased kinase activity in vivo inhibits ADH2 expression, it was suggested that an increase in the cAMP level during growth on glucose would cause the phosphorylation of Adr1, possibly at Ser-230 (54). The phosphorylated Adr1 would still bind to the ADH2 promoter but would not interact with the transcription machinery (337). The existence of ADR1c mutations, which cause enhanced ADH2 transcription under repressed conditions and which interfere with the phosphorylation of Ser-230 in vitro, appeared to support the idea that Adr1 would be regulated by phosphorylation. However, it was concluded later that the ADR1c mutations may be acting by a different mechanism, either blocking the binding of a putative repressor to Adr1 or altering the conformation of Adr1 in such a way that it retains activity in the presence of glucose (75). It should also be noted that phosphorylation of Adr1 in vivo occurs at multiple sites and that the pattern of phosphorylation is similar in glucose- or ethanol-grown cells (354). The existence of an Adr1 homolog in Hansenula polymorpha was suggested by the fact that the promoter of the MOX gene (encoding methanol oxidase) from H. polymorpha is able to bind Adr1 (268). Moreover, the expression of MOX-lacZ in S. cerevisiae is dependent on the endogenous Adr1 and repressed by glucose, as occurs with the ADH2 from S. cerevisiae.Other activators. There are a number of proteins related to catabolite repression which have features of a transcriptional activator but for which no targets have been identified. The characteristics of Sip3 and Sip4 which have been isolated by their capacity to interact with the protein kinase Snf1 in the two-hybrid assay (186, 187) are described in the section on the Snf1 complex (below).
Cat8 is a protein required for the derepression of the gluconeogenic enzymes FbPase, phosphoenolpyruvate carboxykinase, and isocitrate lyase but dispensable for the derepression of invertase or maltase (141). Cat8 is a C6 zinc cluster protein, which is strongly repressed by glucose. Repression still occurs in a hxk2 mutant (278) but is reduced to twofold in the absence of the regulatory protein Mig1 (276, 278). There is a binding site for the Hap2/3/4/5 complex in the promoter of CAT8, and derepression is only partial in a hap2 mutant (278). Although derepression of Cat8, as well as that of the gluconeogenic enzymes, requires the Cat5 protein (276), Cat5 does not seem to be itself an activator of transcription. Cat5 may have only an indirect effect on catabolite repression, its role being to participate in ubiquinone biosynthesis (211). The Cat8 protein undergoes phosphorylation under derepressing conditions yielding different modified forms (279). Two of these forms are found only in SNF1 strains, but another one can be formed in the absence of Snf1. While Snf1 is required for the activation of transcription depending on Cat8 (278), it is not yet known to what extent the Snf1-independent modification is required for Cat8 to be operative. Glucose triggers the dephosphorylation of Cat8, a process which does not appear to require protein phosphatase 1, since it occurs in a glc7 mutant (279).Repressors
The Mig1 complex. The MIG1 gene, an important element in glucose repression, was identified in a search for genes which would turn off the GAL1 promoter of S. cerevisiae (243). Mutations called cat4 or ssn1, which turned out to be allelic to MIG1, were also isolated as extragenic suppressors of snf1 and snf4 mutations (311, 356). Mig1 is a C2H2 zinc finger protein that is able to bind to the promoters of a variety of genes repressed by glucose. Binding requires a GC box with the consensus sequence (G/C)(C/T)GGGG, but it also requires an AT-rich region 5' to the GC box (200). It has been suggested that finger 1 from Mig1 recognizes a G(G/A)G triplet and finger 2 recognizes a (G/C)(C/T)G triplet. The specific residues involved in the contacts would be an arginine at position 21, a histidine at position 18, and an arginine at position 15 for the first finger and an arginine, a glutamic acid, and an arginine at the same positions for the second finger. The AT-rich region would be required to stabilize the interaction, since it would allow bending of the DNA and facilitate further protein-DNA contacts (200).
A LexA-Mig1 fusion protein is able to repress a reporter gene with several Lex operators in a yeast growing on high glucose (352). The repression is much reduced at low glucose concentrations and disappears when galactose is the carbon source (344). A reporter gene containing a Mig1 binding site is also repressed in the presence of glucose; in a snf1 background, repression is maintained even when glucose is removed (365). Deletion mapping of the MIG1 gene has been performed to delineate possible effector domains implicated in the repression by Mig1 and to delineate regulatory domains which would block the repression in the absence of glucose (258). It was found that the C-terminal 24 amino acids of Mig1 are sufficient for repression, when fused to the DNA binding domain. For repression to be relieved as the concentration of glucose in the medium decreases, two internal elements of the Mig1 protein are also required. One of these elements includes two RXXS motifs, potential substrates for some protein kinases. Another important feature of Mig1 is a basic domain 3' to the zinc fingers, which could be involved in targeting Mig1 to the nucleus (258). Although the operation of Mig1 appears to be controlled by the protein kinase Snf1 (258, 344, 365), as yet there is no evidence that Mig1 is actually phosphorylated by Snf1. In the Mig1 sequence, two sites which correspond to the consensus sequence for phosphorylation by Snf1 (defined in reference 68) can be identified, as well as a third site at which Snf1 would be less efficient (Fig. 1). By using a Mig1-viral protein 16 fusion protein that may function as an activator of transcription controlled by Snf1, it has been found that replacing the serines at positions 278, 310, and 311 by alanines affected the phosphorylation state of the fusion protein and strongly decreased the negative effect of Snf1 on its activity (258a). On the other hand, a Mig1 protein with both serines at position 311 and 381, which could be phosphorylated by Snf1, replaced by alanine is still subject to regulation by glucose in the same way as the wild-type protein (365).
|
-transducin
motif (171a, 374). Although these motifs are not absolutely required for repression or for interaction with Cyc8, they appear to
play an important role in Tup1 function (351, 352). Deletion analysis experiments suggest that the N-terminal 72-residue stretch of
Tup1 is necessary and sufficient for the binding of Tup1 to Cyc8. In
addition, Tup1 contains a domain, responsible for repression, which
includes at least two separate transcriptional repression regions.
These regions have little sequence similarity but are characterized by
being alanine rich and almost completely uncharged (351).
Cyc8 is a large protein with a very high proportion of glutamine
residues (313, 345). It contains near its amino terminus 10 copies of a 34-amino-acid motif, the tetratricopeptide repeat TPR
(319). A number of TPR units are required for Cyc8 function (314), and it was proposed that they mediate protein-protein interactions (144). Later, two-hybrid assays showed that the amino-terminal region of Cyc8, comprising the first three TPR motifs
interacts, with Tup1 (352). The two-hybrid system also indicates interaction between Cyc8 and Mig1 (344), and
according to functional tests, TPR motifs 8 to 10 from Cyc8 would be
involved in this interaction (352).
Cyc8 and Tup1 are associated in a high-molecular-weight complex
(375) composed of one Cyc8 and four Tup1 subunits
(359). The Cyc8-Tup1 complex is able to repress different
classes of yeast genes depending on the DNA-binding protein with which
it associates (166). The mechanism by which this complex
exerts transcriptional repression is not yet clear, but two
possibilities, not mutually exclusive, have been considered. Cyc8-Tup1
could modify the chromatin structure and control nucleosome
positioning, and/or it could interfere directly with components of the
basal transcription machinery. Much information on the mode of action of Cyc8-Tup1 has been obtained in studies of the
2-Mcm1-Cyc8-Tup1 complex, which is involved in sexual differentiation. In
cyc8 or tup1 mutants, there is a perturbation in
the placement and stability of nucleosomes around the
2 binding site
(62). There is also evidence for an organized chromatin
structure at the promoter of a gene such as SUC2 under
repressed conditions (145, 217), and in cyc8
mutants an open chromatin structure is observed, even in the presence
of glucose. Further support for the role of Tup1 on chromatin structure
comes from the observation that Tup1 binds to histones H3 and H4
(90). This interaction is weakened by amino-terminal
mutations in H3 and H4, which also cause a derepression of genes
regulated by the Cyc8-Tup1 complex (90). Regarding possible
interactions with the RNA polymerase II complex, recent experiments
suggest that such interactions take place for the
2-Mcm1-Cyc8-Tup1
complex (282).
An important point to consider is how glucose regulates repression by
the Mig1-Cyc8-Tup1 complex. An excess of Mig1 interferes with
derepression of SUC2 and of the GAL genes
and inhibits growth on maltose (243), and
overproduction of Cyc8 or Tup1 reduces the transcription of
SUC2 even in the absence of glucose (313, 374). Nevertheless, neither the amount of Mig1
(243) nor the amounts of Cyc8 and Tup1 (314, 375)
are regulated by glucose. The facts that Mig1 is phosphorylated to
different extents in repressed and derepressed cells and that relief of
Mig1 repression requires the protein kinase Snf1 suggested a role for
phosphorylation of Mig1 in the control of repression (344).
This is strongly supported by recent observations which show that Mig1
is localized in the nucleus in repressed cells and that a few minutes
after glucose removal from the medium, Mig1 is both phosphorylated and translocated to the cytosol (78). A generalized scheme for
the role of Mig1 in catabolite repression is shown in Fig.
2. Although both Cyc8 and Tup1 have been
reported to exist in a phosphorylated form (281, 314), there
is no evidence that changes in their degree of phosphorylation have a
regulatory significance.
|
Other repressors. There is not much evidence about proteins different from the Mig1 family that are able to bind to the promoters of genes subject to catabolite repression and to inhibit the transcription of these genes. The SKO1 gene, which was isolated by the same procedure as MIG1, encodes a protein that is able to bind to the promoter of SUC2, but its role in mediating repression by glucose is doubtful (242). Although transcription of SUC2 is increased up to twofold in a sko1 strain, the effect of the SKO1 disruption is more marked during growth on raffinose than in the presence of glucose. Moreover, the lack of Sko1 has no effect on the expression of GAL genes or on growth on different carbon sources (242).
Since the binding site for Sko1 (Acr1) has the characteristics of a cAMP responsive element (CRE) (242, 363), repression by Sko1 could be due to competition with a potential CRE binding activator, for which some evidence exists (252, 363). In this regard, it should be noted that it has not been yet established whether CRE motifs in S. cerevisiae are really responsive to cAMP. A number of genes have been identified which could formally encode repressors, since mutations in them increase expression of repressible genes in the presence of glucose. However, in most cases, the encoded proteins such as Hxk2, Reg1, or Glc7 have been found not to act directly on the corresponding promoters. In other cases, the genes, such as GAL82 or SRG1 (102, 223), have not yet been cloned, and their mode of action remains obscure. Mutations in different genes (URR1, URR3, and URR4) have been isolated as relieving glucose repression conferred to a heterologous promoter by two different upstream repressor sequences (URSs) from the GAL1 promoter (111, 113). Although it has been suggested that the URR genes encode negative regulators which may be controlled by the Snf1 protein kinase, the genes have not been characterized further.Intermediary Elements
The Snf1 complex.
The SNF1 gene (also
called CAT1 or CCR1) is absolutely required
for the derepression of genes repressed by glucose (40, 58,
399). SNF1 encodes a Ser/Thr protein kinase
(44), the first member of a growing family of protein
kinases to be identified (9). In particular, it has a
mammalian homolog, which is the catalytic
subunit of the
AMP-activated protein kinase (AMPK) (36, 234, 380).
sip2
gal83
triple mutant have no defect in the expression of a GAL gene (101) or the
SUC2 gene (386). It has recently been reported
that the sequence of the
subunit of the mammalian AMPK has 35%
identity to the yeast Sip2 protein and that the sequence of the
subunit is also 35% identical to that of Snf4 (126, 379).
This identity is not restricted to parts of the protein but is found
all along the sequence. Taking into account the homology of function
and sequence of the yeast proteins Sip1, Sip2, and Gal83 (101,
102) and the data on interactions between Snf1, Snf4, and these
proteins (159a), it appears possible that Snf1 participates,
together with Snf4, in a family of complexes containing either Sip1,
Sip2, or Gal83. These complexes may be, at least to some extent,
functionally equivalent, but the observation that a sip1
sip2
gal83
mutant is able to maintain normal regulation of a
set of glucose-repressed genes would suggest the existence of still
unidentified additional regulatory proteins. It would be interesting to
examine whether other genes, such as those encoding gluconeogenic
enzymes, are also unaffected by the triple mutation.
In the mammalian AMPK, the
subunit interacts with both the
and
subunits in vitro but the
and
subunits are unable to
interact under the same conditions (379). Snf1 and Snf4 do not interact in two-hybrid experiments in glucose-grown yeast (159), while Sip1 and Sip2 interact with Snf1
(386). Moreover, Sip1 and Sip2 coimmunoprecipitate with
Snf1, even in the absence of Snf4 (386). However, when the
glucose concentration in the medium is low, there is a direct
interaction between Snf1 and Snf4 in vivo (159). Although
there are no published data on interactions between the Sip proteins
and Snf4, it has been suggested that the Sip1, Sip2, or Gal83 proteins
would act as a bridge between Snf1 and Snf4, bringing them together in
a complex (159).
Genetic and biochemical evidence allows the construction of the model
shown in Fig. 3 for the regulation of the
interactions within the S. cerevisiae Snf1 complex. The
protein kinase Snf1 has two domains: an amino-terminal catalytic domain
(KD) and a carboxy-terminal regulatory domain (RD). Although the
deletion of the regulatory domain bypasses the requirement for Snf4, it does not abolish the repression by glucose (45), and
therefore Snf4 is not the (only) target of the glucose signal. At high
glucose concentrations, the Snf1 regulatory domain binds to the
catalytic domain and inhibits the kinase activity; at low glucose
concentrations, Snf4 interacts with the regulatory domain,
counteracting its inhibitory effect (159). The bridging
protein (Brp), which maintains Snf1 and Snf4 together, could play a
role in the equilibrium between the active and inactive forms of the
Snf1 complex. Two functionally similar dominant mutations
GAL82-1 and GAL83-2000, which partially relieve
glucose repression of the GAL genes, have been isolated (220). The mutant protein Gal83-2000 could have an altered
conformation, allowing at least a partial dissociation of KD and RD in
the presence of glucose and therefore some degree of phosphorylation of
at least a subset of Snf1 substrates. Regarding Gal82-1, no model can
be proposed, because the corresponding gene has not been yet cloned.
|
mutant has no special phenotype, even when
carrying a sip1
, sip2
, or
sip3
mutation. This could indicate that some functional
homolog of Sip4 is operative in S. cerevisiae, although no gene homologous to SIP4 was detected by Southern analysis
under low stringency. The role of Sip4 remains obscure, since no
promoter binding Sip4 has been yet identified and overexpression of
SIP4 is not able to bypass the requirement for Snf4 to
derepress invertase (187).
Very recently, a further protein, Sip5, has been identified
(199). It interacts with both Snf1 and Snf4 and
coimmunoprecipitates with them. It can also interact in the two-hybrid
system with Reg1, a regulatory subunit of the protein phosphatase 1 complex (see the section on the Glc7 complex, below).
In K. lactis, proteins homologous to Snf1 and to the
Gal83, Sip1, Sip2 group have been identified (130). The
KlFOG2 gene is not only homologous to SNF1 but is
also able to complement a snf1 S. cerevisiae mutant.
The KlFOG1 gene encodes a protein with a sequence similar to
that of Gal83, and no genes homologous to FOG1 have been
detected by Southern blotting. It is likely, therefore, that in
K. lactis there is a single complex equivalent to the
family of Snf1 complexes in S. cerevisiae. Besides,
both fog1 and fog2 mutants are unable to grow on
galactose, melibiose, maltose, raffinose, glycerol, ethanol, or
lactate. This can be correlated with the fact that the mutants are
unable to derepress maltase, or L- and
D-lactate ferricytochrome c oxidoreductase. On
the other hand, the fog1 and fog2 mutants are
able to partially derepress invertase and
-galactosidase and can
grow on sucrose or lactose (130). It is not known whether
K. lactis also contains a protein homologous to Snf4
from S. cerevisiae.
The Glc7 complex. GLC7 (DIS2S1) is an essential gene, encoding a protein phosphatase type 1, which controls a variety of processes including glycogen accumulation (108, 254). A mutation called cid1, which partially relieved the repression of invertase by glucose (245), turned out to be a glc7-T152K mutation (348). This mutation did not impair glycogen accumulation (348), while a different mutation, glc7-1, which interfered with glycogen synthesis (34, 267), did not affect the repression of invertase by glucose (348). Since the mutant protein Glc7-1 was shown to be defective in its interaction with Gac1, a protein that appears to be a glycogen-specific regulatory subunit of the protein phosphatase type 1 (330), it was suggested that Glc7-T152K could be impaired in its interaction with a different regulatory protein, which would direct the phosphatase to some substrate(s) specifically related to the control of catabolite repression (348).
A hex2 mutation relieving glucose repression of invertase (97) and a reg1 mutation conferring resistance to catabolite repression of galactokinase synthesis (223) were later found to be allelic (249). When the REG1 gene was cloned and sequenced (250), the sequence did not show significant features, and the role of the corresponding protein remained obscure. However, since the reg1 and glc7-T152K mutations showed similar phenotypes, both suppressed by a snf1 mutation, Reg1 appeared to be a promising candidate for the putative regulatory protein modulating Glc7 activity. A strong interaction between the Reg1 and Glc7 proteins was observed in the two-hybrid system; this interaction decreased markedly when the Glc7 fusion protein carried the T152K mutation (349). Moreover, the LexA-Reg1 and HA-Glc7 fusion proteins were shown to coimmunoprecipitate, and additional evidence that Glc7 and Reg1 work together in glucose repression was provided by the observation that overexpression of REG1 restores glucose repression of invertase in a glc7-T152K mutant (349). On the other hand, it is not yet clear whether glucose can regulate the activity of the Glc7-Reg1 complex. Expression of REG1 is not regulated by glucose (250), and the observation that interaction between Reg1 and Glc7, in the two-hybrid system, is higher in repressed than in derepressed cells could be due to a variety of causes (349). Recently, further glc7 mutants, specifically affected in catabolite repression, were obtained (4). The fact that the mutated residues in the protein phosphatase are clustered on one face of the protein suggests that this is the region where Reg1 binds. Although genetic evidence shows that the Snf1 protein kinase and the Glc7 complex play antagonistic roles, the targets of the phosphatase activity have not yet been identified. Potential candidates would be substrates of Snf1, regulators of Snf1, and the Snf1 protein itself (349). Specifically, it has been proposed that Mig1 would be phosphorylated by Snf1 and dephosphorylated by Glc7 (78). A new protein, Sip5, which is able to interact with Snf1, Snf4 (even in the absence of Snf1), and Reg1 has been identified (199). It could provide a link between the Snf1 and the Glc7 complex. There is also preliminary evidence, using the two-hybrid system, that Reg1 interacts with the catalytic domain of Snf1 (38). It has been reported (189) that Reg1 interacts with the yeast regulatory protein Grr1 (see the next section), and it has been suggested that Grr1 may recognize PEST sequences, a potential signal for protein degradation, in Reg1. The physiological significance of this finding remains unclear: if Grr1 facilitated the degradation of Reg1, reg1 and grr1 mutants would be expected to have opposite phenotypes; instead, they have similar ones (97). A protein of 38 kDa has been identified recently and called Reg2, since it showed a strong similarity to the central region of the 114-kDa protein Reg1 (118). Although this protein interacts with Glc7, it does not appear to play a role in the catabolite repression process.Elements Involved in Glucose Signaling
When glucose is available to yeast, a series of reactions occur whose final result is a change in the amount and/or activity of proteins that bind to gene promoters and modulate their transcription rate. The first signal triggering these reactions may be a charged receptor in the membrane, or a change in the concentration of some intracellular metabolite, including glucose itself. There could be a single signal or several signals, each of which turns on different sets of reactions.
Glucose signaling has a variety of effects. It causes the repression and the inactivation of many enzymes but also the induction and the activation of other enzymes (122). It is possible that some signals cause different kinds of effects while others are more specific for particular systems. For genes encoding glycolytic enzymes and requiring glucose for full expression, induction by glucose depends on the accumulation of intermediary metabolites (16, 18, 238). For some genes, an increase in the level of hexose-6-phosphates is required, while for others, induction is triggered by glycolytic three-carbon metabolites.
There is strong evidence for specific glucose sensors in the yeast membrane. Among the large number of hexose transporter (HXT) genes identified in S. cerevisiae (17, 175), two genes, SNF3 and RGT2, are expressed at very low levels compared to most HXT genes and play a specific regulatory role (247, 259). While SNF3 is repressed by a high concentration of glucose, RGT2 is expressed constitutively. Since Snf3 is required for the induction by low levels of glucose of some hexose transporter genes such as HXT2, it is likely to function as a sensor for low glucose levels. Rgt2, which is required for the induction of HXT1 by high glucose levels, would be a sensor for high glucose levels (259). Since both Snf3 and Rgt2, unlike other glucose transporters, have a long cytoplasmic domain at the C terminus, it has been speculated that the binding of glucose to these proteins causes a conformational change affecting a putative C-terminal signaling domain (47, 259). Since the whole yeast genome has been now sequenced, it can be ascertained that no further protein with a structure similar to that of Snf3 and Rgt2 remains to be discovered (175).
A snf3
mutation does not relieve the repression of
SUC2, GAL10, or ADH2 by high glucose
levels (192, 247), but it abolishes the ability of raffinose
to repress ADH2 (192) and the induction of
SUC2 by low glucose levels (264). While an
rgt2
mutation does not affect the repression of
SUC2 or GAL1 by high glucose levels
(259), an snf3 rgt2 double mutant grows very
poorly in glucose, and in this mutant neither GAL1 nor
SUC2 are repressed by 4% glucose (258b).
It is important to note that signaling by glucose does not have the same requirements for different systems. In a yeast strain with a mutant protein Rgt2-1, a gene such as HXT2 is induced even in the absence of glucose in the medium, suggesting that the signaling domain of the mutant protein is permanently activated. However, in an RGT2-1 strain, the SUC2 gene is still normally derepressed in a medium with low glucose (214).
Could other glucose transporters be involved in the signaling pathway leading to catabolite repression? To address this question, a yeast mutant strain, unable to transport glucose, has been constructed where all the genes from HXT1 to HXT7 are disrupted and a series of derived strains expressing one or several of the genes HXT1 to HXT7 have been studied with regard to their capacity to repress the MAL2, SUC2, or GAL1 genes (283). The results indicate that glucose repression does not depend on any specific transporter but that in the different strains, the extent of repression is correlated with the glucose uptake capacity, suggesting that the rate of glucose utilization determines the strength of the relevant glucose signal. Similarly, it has been reported that in a strain which retains only the HXT6/7 gene and has a low glucose transport capacity, SUC2 is no longer repressed by glucose (368). In contrast to these results, repression of SUC2 and ADH2 was observed in a yeast strain lacking the transport genes HXT1 through HXT4 and HXT6/7, after overnight growth in a medium containing glycerol, ethanol, and 5% glucose (192). It is possible, however, that under these particular conditions other transport genes are expressed at sufficient levels to allow glucose uptake and catabolite repression.
Other reports have shown a correlation between transport capacity and catabolite repression. A yeast strain with the dominant mutation DGT1-1 expresses glucose transporters at low levels, and in this strain glucose repression of a variety of enzymes, including the gluconeogenic ones, is totally or partially relieved while repression by galactose is not affected (120). Another dominant mutation, HTR1-23, has similar but less strong effects (260). HTR1 is allelic to MTH1 (312), and it has now been found that although HTR1-23 and DGT1-1 differ in some of their effects, they are alleles of the same gene (179). MTH1 appears to be involved in the expression of the HXT genes, and although its exact role has not been yet elucidated, another protein, Std1/Msn3, structurally and functionally related to Mth1, has been reported to interact directly with the TATA binding protein (341).
Another mutation, grr1/cat80, isolated as conferring resistance to catabolite repression (3, 97), has also been found to affect the regulation of glucose transporters. Induction of the HXT1 to HXT4 genes is defective in grr1 mutants (261). There is now evidence that Grr1, a large protein with multiple leucine-rich repeats and tightly associated with a particulate fraction (112), is a component of a ubiquitin-conjugating enzyme complex which would regulate, perhaps indirectly, Rgt1 (189). Rgt1 is a DNA-binding protein that is able to repress HXT genes in the absence of glucose and to activate some genes such as HXT1 at high concentrations of glucose (263). Grr1 would be required both at low glucose concentrations to inactivate the Rgt1 repressor function and at high glucose concentrations to turn Rgt1 into an activator. The glucose signal would be transmitted to Grr1 via Snf3 or Rgt2, depending on the concentration of external glucose. In the absence of Grr1, Rgt1 permanently acts as a repressor, the glucose transport capacity of the cell is low, and glucose repression of a number of genes is relieved. In fact, the lack of Rgt1 restores both glucose-induced expression of the HXT1 gene and glucose repression in a grr1 mutant (102, 261, 356a).
In K. lactis, sensitivity to glucose repression is correlated with the hexose transporter genes present in the yeast genome. Strains containing two transporter genes, KHT1 and KHT2, in tandem are very sensitive to glucose. Natural isolates in which most of KHT2 has been lost by a recombination event between KHT1 and KHT2 which generated the gene RAG1 are moderately repressed by glucose. Mutant rag1 strains, which do not synthesize the low-affinity glucose transporter, are nearly insensitive to glucose repression (372).
Among the earliest mutants isolated as defective in catabolite repression were mutants lacking hexokinase II (398); the mutation was first called hex1 (97) and was renamed hxk2 once the affected gene had been identified. Since there are three hexose kinases in S. cerevisiae, hexokinase I, hexokinase II, and glucokinase (195), and the hxk2 mutants can still phosphorylate glucose efficiently, it was first assumed that hexokinase II had a specific regulatory domain required for glucose repression (96). However, the study of a large number of strains with different mutations in the HXK2 gene showed a parallelism between glucose repression and the residual phosphorylating capacity of the mutated hexokinase (205). Later, strains containing either Hxk1 or Hxk2 or hybrid hexokinases between Hxk1 and Hxk2 were constructed, and a strong correlation was found between the capacity of these strains to phosphorylate glucose or fructose and the repression of maltase and invertase by glucose or fructose (290). None of these results supported the hypothesis of a separate regulatory domain in hexokinase II. Hxk2 is phosphorylated in vivo and can be autophosphorylated in vitro (143, 366). Although Hxk2 is more highly phosphorylated when the glucose concentration in the medium is low (366), this phosphorylation does not seem connected with catabolite repression: while the main residue phosphorylated in vivo is Ser-15 (174), a deletion of the N-terminal 15 amino acids of hexokinase II does not affect glucose repression (204).
Kinetic studies, monitoring SUC2 mRNA levels after the addition of glucose to derepressed yeast cells, have shown that glucose has short-term and long-term effects on SUC2 expression (80, 303). Although it is difficult to compare the results of the two groups, since there are wide differences in the experimental conditions, the sugar kinase requirements appear to be different for the two processes. When glucose is added to fully derepressed cells, the early repression response occurs when any of the hexose kinases is present whereas the late response requires Hxk2 (303). On the other hand, while SUC2 expression is not repressed in an hxk2 mutant grown on glucose, growth on fructose has still a strong repressing effect in such a mutant (80).
At this stage, we can conclude that for a sugar to exert catabolite repression, it should be phosphorylated. The extent to which the structure of the phosphorylating protein plays a role in the repression process is still uncertain. However, the recent observation that Hxk2 can be found in the yeast nucleus suggests that this protein plays a regulatory role distinct from its capacity to phosphorylate sugars (279a).
The situation in other yeasts is not uniform. While it has been
reported that mutants of Schwanniomyces occidentalis or
Pachysolen tannophilus lacking a hexokinase
isoenzyme have a defect in catabolite repression (226, 371),
in Candida utilis a strong decrease in hexokinase
activity does not suppress glucose repression of
-glucosidase (103), and in Aspergillus nidulans, too,
hexokinase is not involved in glucose repression
(295).
The next question is how extensively glucose should be metabolized to be able to repress transcription. By using strains with a range of reduced amounts of phosphoglucose isomerase, it has been observed that even when the level of phosphoglucose isomerase is less than 2% of that found in a wild-type yeast, both glucose and fructose strongly repress maltase and invertase (290). It has then been concluded that for catabolite repression, glucose signaling does not require any metabolic step in the glycolytic pathway beyond phosphorylation.
Glucose is known to trigger an immediate, transient increase in the intracellular concentration of cAMP in derepressed cells of S. cerevisiae (225, 357, 373); it is less widely appreciated that glucose also has a long-term effect on cAMP levels. The fact that in different yeasts the intracellular levels of cAMP are higher in the presence of glucose and other sugars than under derepressed conditions (100) could suggest a role for cAMP in catabolite repression.
In S. pombe, where adenylate cyclase is dispensable for growth (207), the gluconeogenic enzyme FbPase is no longer repressed by glucose in strains lacking this enzyme or other elements of the glucose-induced adenylate cyclase activating pathway (28, 147). It is not yet established, however, how general this effect of cAMP is in S. pombe. A very recent report indicates that in a strain where the cyr